MarketCapTrends
CRL

Charles River Laboratories International, Inc. (CRL)

NYSE · Healthcare

Charles River Laboratories International, Inc. annual/quarterly shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Charles River Laboratories International, Inc. shareholder equity for the quarter ending December 27, 2025 were 3.16B, a 8.58% decrease year-over-year.
  • Charles River Laboratories International, Inc. shareholder equity for 2025 were 3.16B, a 8.58% decrease from 2024.
  • Charles River Laboratories International, Inc. shareholder equity for 2024 were 3.46B, a 3.76% decrease from 2023.
  • Charles River Laboratories International, Inc. shareholder equity for 2023 were 3.60B, a 20.85% increase from 2022.
  • Charles River Laboratories International, Inc. shareholder equity for 2022 were 2.98B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Charles River Laboratories International, Inc. Annual Shareholder Equity (Millions of US $)
2025$3,165
2024$3,462
2023$3,597
2022$2,976
2021$2,535
2020$2,115
2019$1,635
2018$1,317
2017$1,045
2016$837
2015$733
2014$672
2013$641
2012$601
2011$526
Charles River Laboratories International, Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-27$3,165
2024-12-28$3,462
2023-12-30$3,597
2022-12-31$2,976
2021-12-25$2,535
2020-12-26$2,115
2019-12-28$1,635
2018-12-29$1,317
2017-12-30$1,045
2016-12-31$837
2015-12-26$733
2014-12-27$672
2013-12-28$641
2012-12-29$601
2011-12-31$526
2010-12-25$687
2009-12-26$1,375

Charles River Laboratories International, Inc. Shareholder Equity — FAQ

Charles River Laboratories International, Inc. (CRL) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRL's shareholder equity history?

The chart and table above show Charles River Laboratories International, Inc.'s shareholder equity by year and by quarter, including the growth rate.